Twinbeech Capital LP Cytokinetics Inc Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $963,754 - $1.2 Million	32,714 New	32,714 $963,000
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.08 Million - $1.53 Million	28,022 New	28,022 $1.36 Million
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $356,097 - $686,458	-19,207 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $380,106 - $518,396	19,207 New	19,207 $380,000

409

125M

4.55M

2.42M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.91B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.